PCLO — Pharmacielo Cashflow Statement
0.000.00%
- CA$16.90m
- CA$37.28m
- CA$1.54m
Annual cashflow statement for Pharmacielo, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -34.7 | -43.8 | -26.6 | -14.5 | -16.3 |
Depreciation | |||||
Non-Cash Items | 12.9 | 16.3 | 12.9 | 4.85 | 7.52 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.65 | 3.31 | -7.58 | -1.79 | 2.22 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -25.2 | -22.6 | -20.1 | -9.88 | -5.15 |
Capital Expenditures | -11.5 | -5.43 | -1.14 | -0.522 | -0.015 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.184 | -0.138 | -0.519 | -0.036 | 0.407 |
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -11.3 | -5.57 | -1.66 | -0.558 | 0.392 |
Financing Cash Flow Items | -0.577 | -1.88 | -1.28 | 0.04 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.51 | 23.3 | 18.2 | 5.3 | 4.63 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -32 | -4.81 | -3.52 | -5.17 | -0.111 |